Michaël Otto

52.6k total citations · 22 hit papers
382 papers, 39.6k citations indexed

About

Michaël Otto is a scholar working on Infectious Diseases, Molecular Biology and Microbiology. According to data from OpenAlex, Michaël Otto has authored 382 papers receiving a total of 39.6k indexed citations (citations by other indexed papers that have themselves been cited), including 261 papers in Infectious Diseases, 252 papers in Molecular Biology and 86 papers in Microbiology. Recurrent topics in Michaël Otto's work include Antimicrobial Resistance in Staphylococcus (200 papers), Bacterial biofilms and quorum sensing (166 papers) and Antimicrobial Peptides and Activities (81 papers). Michaël Otto is often cited by papers focused on Antimicrobial Resistance in Staphylococcus (200 papers), Bacterial biofilms and quorum sensing (166 papers) and Antimicrobial Peptides and Activities (81 papers). Michaël Otto collaborates with scholars based in United States, Germany and China. Michaël Otto's co-authors include Gordon Y. C. Cheung, Cuong Vuong, Frank R. DeLeo, Andreas Peschel, Hwang‐Soo Joo, Amer E. Villaruz, Daniel E. Sturdevant, Barry N. Kreiswirth, Henry F. Chambers and Friedrich Götz and has published in prestigious journals such as Nature, Science and Proceedings of the National Academy of Sciences.

In The Last Decade

Michaël Otto

374 papers receiving 38.6k citations

Hit Papers

Staphylococcus epidermidis — the 'accidenta... 1992 2026 2003 2014 2009 2010 2021 2007 1999 400 800 1.2k
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Staphylococcus epidermidis — the 'accidental' pathogen
    2009 1.3k citations Michaël Otto profile →
  2. Community-associated meticillin-resistant Staphylococcus aureus
    2010 1.2k citations Frank R. DeLeo, Michaël Otto et al. profile →
  3. Pathogenicity and virulence of Staphylococcus aureus
    2021 820 citations Gordon Y. C. Cheung, Michaël Otto et al. profile →
  4. Identification of novel cytolytic peptides as key virulence determinants for community-associated MRSA
    2007 817 citations Kevin R. Braughton, Min Li et al. profile →
  5. Inactivation of the dlt Operon inStaphylococcus aureus Confers Sensitivity to Defensins, Protegrins, and Other Antimicrobial Peptides
    1999 808 citations Michaël Otto, Friedrich Götz et al. profile →
  6. Staphylococcal Biofilms
    2008 728 citations Michaël Otto profile →
  7. Rational Design of Potent, Bioavailable, Nonpeptide Cyclic Ureas as HIV Protease Inhibitors
    1994 680 citations Michaël Otto et al. profile →
  8. Staphylococcus aureus Resistance to Human Defensins and Evasion of Neutrophil Killing via the Novel Virulence Factor Mprf Is Based on Modification of Membrane Lipids with l-Lysine
    2001 622 citations Michaël Otto et al. profile →
  9. Different drugs for bad bugs: antivirulence strategies in the age of antibiotic resistance
    2017 559 citations Gordon Y. C. Cheung, Michaël Otto et al. profile →
  10. The Skeletal Muscle Chloride Channel in Dominant and Recessive Human Myotonia
    1992 556 citations Manuela C. Koch, K. Ricker et al. profile →
  11. Staphylococcus epidermidis infections
    2002 556 citations Michaël Otto et al. Microbes and Infection profile →
  12. Inducible expression of human hepatitis B virus (HBV) in stably transfected hepatoblastoma cells: a novel system for screening potential inhibitors of HBV replication
    1997 517 citations Michaël Otto et al. profile →
  13. Discovery of a β-d-2′-Deoxy-2′-α-fluoro-2′-β-C-methyluridine Nucleotide Prodrug (PSI-7977) for the Treatment of Hepatitis C Virus
    2010 486 citations Michaël Otto et al. profile →
  14. How Staphylococcus aureus biofilms develop their characteristic structure
    2012 474 citations Hwang‐Soo Joo, Anthony C. Duong et al. Proceedings of the National Academy of Sciences profile →
  15. Staphylococcus aureus toxins
    2013 460 citations Michaël Otto profile →
  16. Pathogen elimination by probiotic Bacillus via signalling interference
    2018 455 citations Pipat Piewngam, Hwang‐Soo Joo et al. profile →
  17. Staphylococcal Infections: Mechanisms of Biofilm Maturation and Detachment as Critical Determinants of Pathogenicity
    2012 451 citations Michaël Otto profile →
  18. Staphylococcus δ-toxin induces allergic skin disease by activating mast cells
    2013 409 citations Amer E. Villaruz, Gordon Y. C. Cheung et al. profile →
  19. A Wave of Regulatory T Cells into Neonatal Skin Mediates Tolerance to Commensal Microbes
    2015 404 citations Michaël Otto et al. profile →
  20. Quorum-sensing regulation in staphylococci—an overview
    2015 356 citations Michaël Otto et al. profile →
  21. Commensal Staphylococcus epidermidis contributes to skin barrier homeostasis by generating protective ceramides
    2022 161 citations Amer E. Villaruz, Ryan Liu et al. profile →
  22. Staphylococcus aureus colonisation and strategies for decolonisation
    2024 55 citations Pipat Piewngam, Michaël Otto The Lancet Microbe profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Michaël Otto United States 108 23.2k 19.7k 7.2k 4.7k 3.6k 382 39.6k
Alexander Tomasz United States 96 11.5k 0.5× 13.6k 0.7× 5.0k 0.7× 10.1k 2.2× 4.8k 1.3× 382 29.6k
Victor Nizet United States 108 15.3k 0.7× 8.5k 0.4× 5.8k 0.8× 6.6k 1.4× 2.0k 0.6× 564 43.2k
Julian Parkhill United Kingdom 116 24.8k 1.1× 16.1k 0.8× 5.7k 0.8× 12.1k 2.6× 4.5k 1.3× 566 56.2k
Frank R. DeLeo United States 82 10.9k 0.5× 12.0k 0.6× 2.7k 0.4× 2.5k 0.5× 3.3k 0.9× 189 23.2k
Georg Peters Germany 80 11.1k 0.5× 13.6k 0.7× 2.3k 0.3× 3.7k 0.8× 4.4k 1.2× 332 22.9k
Andreas Peschel Germany 75 11.4k 0.5× 7.4k 0.4× 6.1k 0.9× 1.5k 0.3× 1.1k 0.3× 211 20.2k
Olaf Schneewind United States 92 18.6k 0.8× 10.3k 0.5× 2.7k 0.4× 1.9k 0.4× 999 0.3× 275 29.4k
Dennis L. Kasper United States 84 14.0k 0.6× 6.0k 0.3× 2.8k 0.4× 7.7k 1.6× 1.2k 0.3× 292 30.2k
Alex van Belkum Netherlands 81 9.9k 0.4× 15.0k 0.8× 2.4k 0.3× 5.8k 1.2× 6.6k 1.9× 528 28.6k
Friedrich Götz Germany 80 14.1k 0.6× 8.2k 0.4× 4.1k 0.6× 1.3k 0.3× 1.1k 0.3× 336 22.3k

Countries citing papers authored by Michaël Otto

Since Specialization
Citations

This map shows the geographic impact of Michaël Otto's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michaël Otto with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michaël Otto more than expected).

Fields of papers citing papers by Michaël Otto

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michaël Otto. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michaël Otto. The network helps show where Michaël Otto may publish in the future.

Co-authorship network of co-authors of Michaël Otto

This figure shows the co-authorship network connecting the top 25 collaborators of Michaël Otto. A scholar is included among the top collaborators of Michaël Otto based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michaël Otto. Michaël Otto is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Berkova, Nadia, Éric Guédon, Yves Le Loir, & Michaël Otto. (2025). Host DNA damage and cellular fate in bacterial infections, with a focus on Staphylococcus aureus. FEMS Microbiology Reviews. 49.
2.
Piewngam, Pipat & Michaël Otto. (2024). Staphylococcus aureus colonisation and strategies for decolonisation. The Lancet Microbe. 5(6). e606–e618. 55 indexed citations breakdown →
3.
4.
5.
Liu, Ryan, et al.. (2022). Investigational agents for the treatment of methicillin-resistant Staphylococcus aureus (MRSA) bacteremia: progress in clinical trials. Expert Opinion on Investigational Drugs. 31(3). 263–279. 8 indexed citations
6.
Laabei, Maisem, Eóin C. O’Brien, Keenan A. Lacey, et al.. (2020). A Small Membrane Stabilizing Protein Critical to the Pathogenicity of Staphylococcus aureus. Infection and Immunity. 88(9). 11 indexed citations
7.
Jones, Dennis, Eelco F. J. Meijer, Cédric Blatter, et al.. (2018). Methicillin-resistant Staphylococcus aureus causes sustained collecting lymphatic vessel dysfunction. Science Translational Medicine. 10(424). 50 indexed citations
8.
Ebner, Patrick, Arif Luqman, Sebastian Reichert, et al.. (2017). Non-classical Protein Excretion Is Boosted by PSMα-Induced Cell Leakage. Cell Reports. 20(6). 1278–1286. 52 indexed citations
9.
Joo, Hwang‐Soo, et al.. (2016). Bacterial strategies of resistance to antimicrobial peptides. Philosophical Transactions of the Royal Society B Biological Sciences. 371(1695). 20150292–20150292. 256 indexed citations
10.
Chen, Yan, Anthony J. Yeh, Gordon Y. C. Cheung, et al.. (2014). Basis of Virulence in a Panton-Valentine Leukocidin-Negative Community-Associated Methicillin-ResistantStaphylococcus aureusStrain. The Journal of Infectious Diseases. 211(3). 472–480. 27 indexed citations
11.
Otto, Michaël. (2013). How colonization factors are linked to outbreaks of methicillin-resistant Staphylococcus aureus : the roles of SasX and ACME. BioMolecular Concepts. 4(5). 533–537. 8 indexed citations
12.
Otto, Michaël. (2013). Community-associated MRSA: What makes them special?. International Journal of Medical Microbiology. 303(6-7). 324–330. 255 indexed citations
13.
Rosenthal, Marnie, Lisa L. Dever, Calin S. Moucha, et al.. (2011). Molecular Characterization of an Early Invasive Staphylococcus epidermidis Prosthetic Joint Infection. Microbial Drug Resistance. 17(3). 345–350. 9 indexed citations
14.
DeLeo, Frank R., Adam D. Kennedy, Liang Chen, et al.. (2011). Molecular differentiation of historic phage-type 80/81 and contemporary epidemic Staphylococcus aureus. Proceedings of the National Academy of Sciences. 108(44). 18091–18096. 120 indexed citations
15.
Cheung, Gordon Y. C., Anthony C. Duong, & Michaël Otto. (2011). Direct and synergistic hemolysis caused by Staphylococcus phenol-soluble modulins: implications for diagnosis and pathogenesis. Microbes and Infection. 14(4). 380–386. 98 indexed citations
16.
Li, Min, Binh An Diep, Amer E. Villaruz, et al.. (2009). Evolution of virulence in epidemic community-associated methicillin-resistant Staphylococcus aureus. Proceedings of the National Academy of Sciences. 106(14). 5883–5888. 322 indexed citations
17.
Miragaia, Maria, Hermı́nia de Lencastre, Françoise Perdreau‐Remington, et al.. (2009). Genetic Diversity of Arginine Catabolic Mobile Element in Staphylococcus epidermidis. PLoS ONE. 4(11). e7722–e7722. 93 indexed citations
18.
Kennedy, Adam D., Michaël Otto, Kevin R. Braughton, et al.. (2008). Epidemic community-associated methicillin-resistant Staphylococcus aureus : Recent clonal expansion and diversification. Proceedings of the National Academy of Sciences. 105(4). 1327–1332. 300 indexed citations
19.
Timmins, Graham S., Michael Harris, Xian Chen, et al.. (2004). Inactivation of a bacterial virulence pheromone by phagocyte-derived oxidants: New role for the NADPH oxidase in host defense. Proceedings of the National Academy of Sciences. 101(38). 13867–13872. 89 indexed citations
20.
Ricker, K., et al.. (1994). A recurrent 14 bp deletion in the CLCN1 gene associated with generalized myotonia (Becker). Human Molecular Genetics. 3(6). 1015–1016. 25 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Alexander Tomasz Breakdown of academic impact, for papers by Victor Nizet Breakdown of academic impact, for papers by Julian Parkhill Breakdown of academic impact, for papers by Frank R. DeLeo Breakdown of academic impact, for papers by Georg Peters Breakdown of academic impact, for papers by Andreas Peschel Breakdown of academic impact, for papers by Olaf Schneewind Breakdown of academic impact, for papers by Dennis L. Kasper Breakdown of academic impact, for papers by Alex van Belkum Breakdown of academic impact, for papers by Friedrich Götz
Rankless by CCL
2026